...
机译:全球跨公司数据共享倡议的建议对安全评估研究中的复苏阶段动物纳入,以支持一中临床试验
UK Natl Ctr Replacement Refinement &
Reduct Anim London NW1 2BE England;
UK Natl Ctr Replacement Refinement &
Reduct Anim London NW1 2BE England;
Covance Labs Ltd Harrogate HG3 1PY England;
Vertex Pharmaceut Inc Boston MA 02139 USA;
Huntingdon Life Sci Ltd Eye IP23 7PX Suffolk England;
FDA Silver Spring MD 20993 USA;
Gilead Sci Inc Foster City CA 94404 USA;
Biogen Idec Inc Cambridge MA 02142 USA;
Infin Pharmaceut Cambridge MA 02139 USA;
Genentech Inc San Francisco CA 94080 USA;
Bayer Pharrna AG D-13353 Berlin Germany;
Charles River Labs Preclin Serv Edinburgh EH33 2NE Midlothian Scotland;
Merck West Point PA 19486 USA;
Medlmmune Cambridge CB21 6GH England;
Austrian Agcy Hlth &
Food Safety A-1200 Vienna Austria;
NIBR Basel Switzerland;
Roche Innovat Ctr Basel Roche Pharmaceut Res &
Early Dev CH-4070 Basel Switzerland;
FDA Silver Spring MD 20993 USA;
FDA Silver Spring MD 20993 USA;
Celgene Summit NJ 07901 USA;
AbbVie Deutschland GmbH &
Co KG D-67061 Ludwigshafen Germany;
Novo Nordisk AS Malov Denmark;
Huntingdon Life Sci Ltd Huntingdon PE28 4HS Cambs England;
Univ Eastern Finland Fac Hlth Sci Sch Pharm Kuopio Finland;
Pfizer Drug Safety Res &
Dev Groton CT 06340 USA;
NC3Rs Board Member London NW1 2BE England;
AstraZeneca Macclesfield SK10 4TG Cheshire England;
Paul Ehrlich Inst Fed Agcy Vaccines &
Biomed Langen Germany;
Allergan Drug Safety Evaluat Irvine CA 92612 USA;
Univ Lisbon IMED UL P-1699 Lisbon Portugal;
Takeda Oncol Co Millenium Cambridge MA USA;
GlaxoSmithKline Ware SG12 0DP Herts England;
Janssen Res &
Dev B-2340 Beerse Belgium;
Med Healthcare Prod Regulatory Agcy MHRA London England;
Recovery; Reversibility; 3Rs; Reduction; Non-clinical; Repeat-dose studies; Regulatory toxicology; Rodent; Primate; Dog;
机译:来自全球跨公司数据共享计划的建议,关于将恢复期动物纳入安全性评估研究中以支持首次人体临床试验
机译:全球跨公司数据共享倡议的建议对安全评估研究中的复苏阶段动物纳入,以支持一中临床试验
机译:关于使用恢复动物进行人类安全评估的全球跨公司数据共享
机译:STEM-32。神经干细胞介导的羧化酶/异丁烯酸酶/药物前体基因疗法治疗人脑胶质瘤至临床第一阶段的临床前安全性和有效性研究
机译:来自全球跨公司数据共享计划的建议,关于将恢复期动物纳入安全性评估研究中以支持首次人体临床试验